Tom Henley

Company: Intima Bioscience

Job title: Chief Scientific Officer

Seminars:

Utilizing Multiplex CRISPR Gene Editing to Assess New Classes of Intra Cellular Immune Checkpoint Molecules for Application in TIL 12:30 pm

• Comparing the function of CISH deletion relative to both extracellular and intracellular immune checkpoints in neoantigen cytolysis models • Demonstrating intra-cellular immune checkpoint protein CISH can potentially enhance anti-tumor responses against a broad range of cancer types regardless of PD-L1 biomarker status • Considering next generation checkpoints and the application to TILRead more

day: Day Two